| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 367.6K | $11.57M | - | |
| VP | 63.6K | $2.00M | - | |
| Other | 52.8K | $1.66M | - | |
| Other | 52.7K | $1.66M | - | |
| VP | 13.0K | $410.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2018 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 2,358 | $18.38 | $43,340.04 | -44.2% | |
| Mar 19, 2018 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 1,179 | $17.88 | $21,078.16 | -45.9% | |
| Mar 19, 2018 | Nazzi Gianfranco | EVP, Growth Markets Commercial | Sale+OE | 457 | $17.89 | $8,176.64 | -7.4% | |
| Mar 19, 2018 | McClellan Michael James | EVP, Chief Financial Officer | Sale+OE | 287 | $17.88 | $5,130.99 | -2.5% | |
| Mar 19, 2018 | Griffin Deborah A | Chief Accounting Officer | Sale+OE | 943 | $17.88 | $16,858.95 | -100% | |
| Mar 19, 2018 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 348 | $17.88 | $6,221.54 | -2.4% | |
| Mar 19, 2018 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 571 | $17.88 | $10,208.34 | -11.4% | |
| Mar 19, 2018 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 1,297 | $17.89 | $23,205.92 | -100% | |
| Mar 12, 2018 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 2,441 | $19.20 | $46,867.20 | -45.1% | |
| Mar 12, 2018 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 738 | $19.49 | $14,382.88 | -34.7% |